BASILIXIMAB SAROTALOCAN

UNII:	CED3FF7MXQ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	BASILIXIMAB SAROTALOCAN
GSRS Full Record:	CED3FF7MXQ i

2417483-64-6
Basiliximab Sarotalocan
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CHI621 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CHI621 LIGHT CHAIN, DIMER, N6-(1-OXO-6-(((3-((29H,31H-PHTHALOCYANIN-1-YL-.KAPPA.N29,.KAPPA.N30,.KAPPA.N31,.KAPPA.N32)OXY)PROPOXY)CARBONYL)AMINO)HEXYL)-L-LYSINE, COMPLEX WITH BIS((DIMETHYL(3-(TRIS(3-SULFOPROPYL)AMMONIO)PROPYL)SILYL)OXY)SILICONE, BIS(INNER SALT), SODIUM SALT (1:4)
basiliximab sarotalocan [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BASILIXIMAB SAROTALOCAN

Synonyms and Mappings

Resources